Terms: = Kidney tumors AND CALCB, Calcitonin
124 results:
1. Tumor-to-Tumor Metastasis of Medullary Thyroid Carcinoma to Paraganglioma in a Multiple Endocrine Neoplasia Type 2B Patient: A Case Report and Literature Review.
Takido N; Saito R; Okada K; Kanai N; Shono Y; Mitsugashira H; Matsumura M; Sasaki K; Miyazawa K; Fujio A; Tokodai K; Murakami K; Sasano H; Unno M; Ishida T; Kamei T
Tohoku J Exp Med; 2023 Sep; 261(1):75-81. PubMed ID: 37468258
[TBL] [Abstract] [Full Text] [Related]
2. Cancer-related hypercalcemia and potential treatments.
Almuradova E; Cicin I
Front Endocrinol (Lausanne); 2023; 14():1039490. PubMed ID: 37033238
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract] [Full Text] [Related]
4. Milk-Alkali Syndrome: How Electronic Medical Record Open Notes Helped to Rule Out Cancer.
Rizk MA; Abourizk N; Kovalenko I; Golubykh K; Soni B; Zaccheo M; Zanders S
Am J Case Rep; 2022 Sep; 23():e936969. PubMed ID: 36056538
[TBL] [Abstract] [Full Text] [Related]
5. Gender-Dependent Reference Range of Serum calcitonin Levels in Healthy Korean Adults.
Song E; Jeon MJ; Yoo HJ; Bae SJ; Kim TY; Kim WB; Shong YK; Kim HK; Kim WG
Endocrinol Metab (Seoul); 2021 Apr; 36(2):365-373. PubMed ID: 33823567
[TBL] [Abstract] [Full Text] [Related]
6. Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report.
Johnson K; Issa M; Parikh A; Monk P; Yin M; Mortazavi A; Yang Y
BMC Urol; 2021 Apr; 21(1):51. PubMed ID: 33794867
[TBL] [Abstract] [Full Text] [Related]
7. Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy.
Sheehan MT; Wermers RA; Jatoi A; Loprinzi CL; Onitilo AA
Med Hypotheses; 2020 Oct; 143():110149. PubMed ID: 32763659
[TBL] [Abstract] [Full Text] [Related]
8. calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
[TBL] [Abstract] [Full Text] [Related]
9. Medullary Thyroid Carcinoma: Prognostic Variables And Tumour Markers Affecting Survival.
Hassan A; Siddique M; Riaz S; Khan AI; Nawaz MK; Bashir H
J Ayub Med Coll Abbottabad; 2018; 30(Suppl 1)(4):S627-S632. PubMed ID: 30838820
[TBL] [Abstract] [Full Text] [Related]
10. Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.
Mahmoud S; Mitwally H; El Zeer HS; El Madhoun I; Khatib M
Am J Case Rep; 2018 Sep; 19():1087-1089. PubMed ID: 30209247
[TBL] [Abstract] [Full Text] [Related]
11. [Recommendation for calcitonin Screening in Nodular Goiter].
Frank-Raue K; Schott M; Raue F;
Dtsch Med Wochenschr; 2018 Aug; 143(15):1065-1069. PubMed ID: 30060274
[TBL] [Abstract] [Full Text] [Related]
12. Treatment of extreme hypercalcaemia: the role of haemodialysis.
Basok AB; Rogachev B; Haviv YS; Vorobiov M
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866671
[TBL] [Abstract] [Full Text] [Related]
13. Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone.
Uday S; Gaston CL; Rogers L; Parry M; Joffe J; Pearson J; Sutton D; Grimer R; Högler W
J Clin Endocrinol Metab; 2018 Feb; 103(2):596-603. PubMed ID: 29211870
[TBL] [Abstract] [Full Text] [Related]
14. Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.
Russell L; Madsen MB; Dahl M; Kampmann P; Perner A
Acta Anaesthesiol Scand; 2018 Feb; 62(2):196-206. PubMed ID: 29124749
[TBL] [Abstract] [Full Text] [Related]
15. Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.
Hirokawa M; Miyauchi A; Kihara M; Kudo T; Hashimoto Y; Suzuki S; Daa T; Vuong HG; Mitsutake N
Endocr J; 2017 Sep; 64(9):843-850. PubMed ID: 28680002
[TBL] [Abstract] [Full Text] [Related]
16. Humoral Hypercalcemia in Uterine Cancers: A Case Report and Literature Review.
Motilal Nehru V; Garcia G; Ding J; Kong F; Dai Q
Am J Case Rep; 2017 Jan; 18():22-25. PubMed ID: 28057913
[TBL] [Abstract] [Full Text] [Related]
17. kidney Involvement in Systemic calcitonin Amyloidosis Associated With Medullary Thyroid Carcinoma.
Koopman T; Niedlich-den Herder C; Stegeman CA; Links TP; Bijzet J; Hazenberg BPC; Diepstra A
Am J Kidney Dis; 2017 Apr; 69(4):546-549. PubMed ID: 28024929
[TBL] [Abstract] [Full Text] [Related]
18. Association of urothelial carcinoma of the renal pelvis with papillary and medullary thyroid carcinomas. A new sporadic neoplastic syndrome?
Albores-Saavedra J; Dorantes-Heredia R; Chablé-Montero F; Córdova-Ramón JC; Henson DE
Ann Diagn Pathol; 2014 Oct; 18(5):286-90. PubMed ID: 25175810
[TBL] [Abstract] [Full Text] [Related]
19. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma.
Kwon H; Kim WG; Choi YM; Jang EK; Jeon MJ; Song DE; Baek JH; Ryu JS; Hong SJ; Kim TY; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2015 Apr; 82(4):598-603. PubMed ID: 25041034
[TBL] [Abstract] [Full Text] [Related]
20. [Refractory hypercalcemia in patient with lung cancer].
Grzywacz A; Dziuk M; Niemczyk S
Pol Merkur Lekarski; 2014 Apr; 36(214):261-4. PubMed ID: 24868900
[TBL] [Abstract] [Full Text] [Related]
[Next]
